Mar 8 |
Regenxbio raised to Buy at RBC on pivot to Duchenne
|
Mar 8 |
Regenxbio Inc (RGNX) Chief Medical Officer Steve Pakola Sells 12,878 Shares
|
Mar 7 |
Bearish: Analysts Just Cut Their REGENXBIO Inc. (NASDAQ:RGNX) Revenue and EPS estimates
|
Mar 7 |
REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants
|
Mar 6 |
REGENXBIO stock falls after co announces $125M equity raise
|
Mar 6 |
REGENXBIO Announces Proposed Public Offering of Common Stock
|
Mar 6 |
REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study
|
Mar 6 |
Regenxbio data suggest ‘niche’ in Duchenne gene therapy
|
Mar 5 |
Regenxbio stock jumps 13% on positive data for DMD drug
|
Mar 5 |
REGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM AFFINITY DUCHENNE® TRIAL
|